FDA clears Moderna's RSV vaccine for use in people aged 18 to 59
'RSV poses a serious health risk to adults with certain chronic conditions, and today's approval marks an important step forward in our ability to protect additional populations from severe illness from RSV,' Moderna CEO Stéphane Bancel, said in a statement.
Advertisement
The approval was a welcome win for the Cambridge-based company, which has faced several setbacks of late due to deep distrust of its messenger RNA vaccine platform among supporters of health secretary Robert F. Kennedy Jr.
A number
The next step in the vaccine's path to expanded use has already been cleared. At a meeting in April, the Center for Disease Control and Prevention's expert vaccines panel, the Advisory Committee on Immunization Practices, voted to recommend use of RSV vaccine
Advertisement
At the time of the vote, only two of the three licensed RSV vaccines — Pfizer's Abryso and GSK's Arexvy — were licensed for use in adults under the age of 60. The committee's recommendation was worded in such a way as to include any RSV with a license for use in this age group, so should, in theory, apply as well to the Moderna vaccine now that the age extension has been endorsed by the FDA.
But that ACIP recommendation is currently in limbo. A recommendation from the advisory body must be approved by the CDC director or the secretary of the Health and Human Services Department in order to come into force. There is currently no CDC director and in the nearly two months since ACIP endorsed the recommendation, Kennedy has chosen not to sign off on it. He did, however, approve three other recommendations the committee made related to use of chikungunya vaccines.
Without a recommendation from the ACIP that has been accepted by the CDC director or the health secretary, the vaccine can be administered to an individual in the new age group, but health insurers do not have to cover its cost.
Kennedy
Advertisement
Late last month Moderna
The company said it will have mRESVIA available in the U.S. for both younger adults at increased risk — the ages 18 to 59 cohort — and adults aged 60 and older for the 2025-2026 respiratory virus season.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Post
4 hours ago
- New York Post
This common kitchen herb ingredient could help target or slow Alzheimer's
Experts believe they've identified a chemical compound in certain herbs that could help mitigate or prevent Alzheimer's disease — but before anyone makes a run for the spice rack, there are a few catches. In a study published in the journal Antioxidants earlier this year, researchers from the Scripps Research Institute identified a compound called carnosic acid, which is prevalent in rosemary and sage. Advertisement The compound could prove therapeutic for neurodegenerative disorders, including Alzheimer's disease, the experts concluded. Carnosic acid contains 'striking antioxidant [and] anti-inflammatory properties,' the researchers wrote in the findings. Scripps Research postdoctoral associate Piu Banerjee and board-certified neurologist Dr. Stuart Lipton, based in California, spoke with Fox News Digital about the results. 'In this study, we observed that administering this drug to mice that had advanced Alzheimer's-like disease significantly improved the number of neurons, as well as the number of synapses or connections between the brain cells,' the team said. Advertisement 4 Experts believe they've identified a chemical compound, carnosic acid, in certain herbs like rosemary and sage that could help mitigate or prevent Alzheimer's disease. Brent Hofacker – The experts added, 'It also reduced inflammation that is caused by the current anti-amyloid antibody therapies. We also observed an improvement in the learning and memory behavior of the mice that received the drug.' Banerjee and Lipton also noted that carnosic acid is a 'prodrug,' meaning it's inactive at first — but once it enters the body, it's activated by oxidative and inflammatory stress. 'It specifically targets cells undergoing oxidative and inflammatory stress, without affecting the healthy, normal brain cells,' Banerjee said. Advertisement 'This further makes it a safe option for therapeutics.' The experts agreed that carnosic acid could potentially improve the inflammation that generally occurs in most aging brains. There are cautions, however. Advertisement Courtney Kloske, director of scientific engagement for the Chicago-based Alzheimer's Association, told Fox News Digital that studies based on a mouse model of Alzheimer's can be helpful but are not conclusive. 4 Experts say carnosic acid could improve inflammation occurring in most aging brains. LIGHTFIELD STUDIOS – 'Models are important in helping us understand the basic biology of the disease, but we need human studies in representative populations for ideas to be fully validated,' Kloske said. 'Therefore, while these are intriguing findings, more research is needed to understand the impacts and outcomes of these compounds on people living with, or at risk for, Alzheimer's.' Cooking sage and rosemary won't provide the full anti-inflammatory effects, Banerjee and Lipton stressed. 4 'We need human studies in representative populations for ideas to be fully validated,' Courtney Kloske, director of scientific engagement for the Chicago-based Alzheimer's Association, says about the limitations of the information. – 'Critically, one cannot take sufficient herbs safely to produce the same effect as our new drug,' Banerjee said. The study, funded in part by the National Institutes of Health, did have some limitations, the researchers acknowledged. Advertisement Kloske advised that, at this point, 'no one should consume these herbs (or carnosic acid) to prevent or treat Alzheimer's or other cognitive impairment.' 4 According to Scripps Research postdoctoral associate Piu Banerjee and board-certified neurologist Dr. Stuart Lipton, cooking sage and rosemary won't provide the full anti-inflammatory effects. Ganna – Dr. Lee Murray, a neurologist in Jackson, Tennessee, echoed Kloske's concerns. 'Before patients start incorporating rosemary and sage in every dish they eat, we need to remember these studies are pre-clinical,' Murray told Fox News Digital. Advertisement 'Currently, there is insufficient clinical evidence to recommend rosemary and sage as a standard therapy for Alzheimer's dementia.' Murray, however, said the data 'is encouraging' and opens the door to additional pathways for potential therapeutics. Banerjee said she hopes that 'our drug will start human clinical trials soon.' She added, 'If it proves to be effective, it will be a great new drug for those suffering from Alzheimer's … From the results of our animal studies, we are cautiously optimistic for its success in human clinical trials.'
Chicago Tribune
4 hours ago
- Chicago Tribune
President of Daley's ambulance company, started by his dad, dies at 67
A memorial service is planned for John 'Jack' Daley III, president and chief executive officer of Daley's Medical Transportation, who died June 23, according to the company. The Oak Lawn resident was 67, and Daley's said he was surrounded by family and friends at home when he died following a long battle with pancreatic cancer. Dolton-based Daley's operates Bud's Ambulance, which provides paramedic-level ambulance response to 10 south suburbs. It also has a Joliet division that operates as Daley's Ambulance. Daley's Ambulance was founded in Harvey in 1950 by Daley's father, John 'Bud' Daley Jr. Daley's Medical said Daley was diagnosed with pancreatic cancer in May 2023, and he was 'determined not to let cancer hold him back. Even chemotherapy wasn't going to stop him from running ambulance calls.' 'Helping other people and caring for patients is what kept him alive,' the company said in announcing his passing. 'Jack Daley will always be the strongest and most resilient person we have ever known,' the company said. Daley's survivors include his wife and four daughters. The company said a memorial service will be announced at a later date. The company said Daley was a paramedic for 49 years in south Cook County and had been a police officer with the Burnham Police Department since 1980, rising to the rank of sergeant and serving on the South Suburban Major Crimes Task Force for more than 10 years. The company's main office has been in Dolton since 1972 and it also has a location in Joliet that opened in 2012. John 'Bud' Daley founded the business in September 1950 after serving in the military, first as a corpsman in Korea then later managing a military ambulance on the Philippine Islands, according to a company history. Daley left the military in 1949, then after returning stateside worked for an ambulance company in Fargo, North Dakota, according to the company's history. The business was based at his home in Harvey, and Daley, in 1955, married Betty, who became his partner in the business and would answer the phone and communicate on the radio perched on the kitchen table. Daley's Ambulance, as it was known at the time, started with two used ambulances — a 1936 LaSalle and 1946 Packard — according to the company. It was Daley's experience in the military and overseeing the Army ambulance that made him realize that 'medically trained personnel should be available to everyone in a time of need,' according to the company. Daley died in 2001, and Jack formed Bud's Ambulance at the time. Daley's Medical Transportation also operates Daley's Ambulance in Will County. It responds to 911 calls in Rockdale and also serves multiple health care facilities in Will County, according to the company. Nearly all of Daley's employees are either trained and certified as emergency medical technicians or paramedics, according to John McGehee, vice president of administration. The company requires that executives go out on ambulance runs and work alongside crews on a regular basis.
Atlantic
4 hours ago
- Atlantic
RFK Jr. Is Globalizing the Anti-Vaccine Agenda
This week, Robert F. Kennedy Jr. used his address to a global vaccine summit to disparage global vaccination. The conference was organized by Gavi, the world's leading immunization program, and in a recorded speech, Kennedy accused the organization of collaborating with social-media companies to stifle dissenting views on immunization during the coronavirus pandemic and said it had 'ignored the science' in its work. He criticized Gavi for recommending COVID-19 shots to pregnant women, and went deep on a discredited study that purported to find safety issues with a tetanus vaccine commonly used in the developing world. 'In its zeal to promote universal vaccination,' Kennedy claimed, Gavi 'has neglected the key issue of vaccine safety.' Kennedy's remarks confirmed what The New York Times first reported in March: that the United States, Gavi's third-largest donor, would stop pledging money to the organization. (Congress, which has always had final say over Gavi funding, has not yet weighed in.) They are also the first indication that the U.S.'s rejection of global vaccine campaigns stems from the Trump administration's opposition not only to foreign aid, but to vaccination itself. For the first time, Kennedy has managed to use the anti-vaccine agenda to guide American foreign policy. Gavi, at its most basic level, is Costco for immunizations, wielding its massive purchasing power to buy vaccines in bulk for cheap. National governments and private philanthropies pledge funding to it every five years. The United Kingdom and the Gates Foundation are its largest donors; the United Nations distributes the shots. The poorest countries pay 20 cents per vaccine, and prices rise along with national income. Since the partnership was launched, in January 2000, 19 countries —including Ukraine, Congo, and Guyana—have gone from relying on Gavi to paying for vaccinations entirely on their own. Indonesia, which accepted donations from Gavi as recently as 2017, pledged $30 million to the organization this funding cycle. Gavi, by its own estimate, has saved about 19 million lives and vaccinated 1 billion children. At the conference this week, the director of the World Health Organization noted that since 2000, the number of children who die each year before they reach the age of 5 has fallen by more than half, largely due to the power of vaccines. By Gavi's estimates, the U.S. canceling its Biden-era pledge to provide $1.2 billion this donation cycle could lead to the deaths of more than 1 million children who otherwise would have lived. (The Department of Health and Human Services did not respond to a request for comment.) In his recorded remarks, Kennedy said America would not send the money until Gavi can 're-earn the public trust' by 'taking vaccine safety seriously.' Cutting off millions of children's only access to routine vaccines is 'the most emphatic globalization of the anti-vaxxer agenda,' Lawrence Gostin, the faculty director of Georgetown's O'Neill Institute for National and Global Health Law, told me. Tom Frieden, the former director of the CDC, told me that after he heard Kennedy's remarks, 'I was literally sick to my stomach,' because 'unscientific, irresponsible statements like this will result in the deaths of children.' (The U.S. has run an international anti-vaccine campaign before: According to an investigation by Reuters, in 2020, the Pentagon unleashed bot accounts on multiple social-media platforms that impersonated Filipinos and discouraged uptake of China's Sinovac vaccine—the first COVID vaccine available in the Philippines—using a hashtag that read, in Tagalog, 'China is the virus.' The goal was not to combat vaccines, but to undermine China's influence.) Kennedy's prerecorded address held back his harshest critiques of Gavi. In his 2021 book, The Real Anthony Fauci, Kennedy paints 'Bill Gates's surrogate group Gavi' (the Gates Foundation co-founded Gavi) as nothing more than a profiteering 'cabal' and a facilitator of 'African Genocide.' To hear Kennedy tell it, 'virtually all of Gates's blockbuster African and Asian vaccines—polio, DTP, hepatitis B, malaria, meningitis, HPV, and Hib—cause far more injuries and deaths than they avert.' Decades' worth of safety and efficacy studies have proved him wrong. In his remarks to Gavi this week, Kennedy focused on the DTP (diphtheria, tetanus, and pertussis) shot, describing at length a 'landmark' 2017 study that found the vaccine increased all-cause mortality among girls in Guinea-Bissau. But as Frieden pointed out, this was in fact a relatively small observational study. In 2022, a randomized, double-blind, placebo-controlled trial of more than 50,000 newborns found that the DTP vaccine significantly decreased infant mortality. Frieden compared the evidence: 'Hundreds of kids versus 50,000 kids. Poorly done; well done.' Kennedy made efforts to take his anti-vaccine advocacy global before he became America's health secretary. In 2021, he delivered a webinar on the importance of expanding an 'international movement' for Children's Health Defense, the anti-vaccine organization he founded. In 2019, when Samoa was experiencing a major dip in measles immunization after an improperly prepared vaccine killed two children, Kennedy visited the prime minister and, on behalf of Children's Health Defense, reportedly offered to build an information system the country could use to track the health effects of vaccines and other medical interventions. When a deadly measles outbreak took hold later that year, Kennedy sent a letter to the prime minister suggesting that widespread vaccination might make unvaccinated Samoan children more likely to die of measles. (In an interview for a 2023 documentary, Kennedy said that 'I had nothing to do with people not vaccinating in Samoa' and that his conversations about vaccines with the prime minister had been 'limited.') Now, it seems, Kennedy has gained the power to realize his ambitions both domestically and abroad. Earlier this month, Kennedy dismissed all 17 members of the CDC's vaccine advisory committee, then replaced them with a group that includes several allies who have spread misinformation about the harms of vaccines. This week, as other countries pledged their support for Gavi, Kennedy's brand-new, handpicked panel convened for a discussion of the dangers of thimerosal, a vaccine ingredient that is a frequent target of anti-vaxxers despite having been found safe. The committee has formed a working group to review the 'cumulative effect' of childhood vaccination in the United States. As Kennedy said in his address to Gavi, 'Business as usual is over.'
